Goldman Sachs removed Interactive Brokers (IBKR) from its U.S. Conviction List in its September monthly update. The list features stocks with analysts' highest conviction for outperformance. The removal suggests reduced near-term conviction from Goldman Sachs. The bank reportedly maintained a "Buy" rating on IBKR.
This change was part of a broader refresh. Vertex Pharmaceuticals (VRTX) joined the U.S. list.
Shares of Interactive Brokers faced downward pressure following the announcement. This move, combined with a concurrent neutral rating initiation from UBS, prompted profit-taking in the stock.